… review, immunotherapy is an efficient therapeutic option intervention against COVID-19 and
the … and plasma therapy have improved clinical outcomes in COVID-19 infected patients. …

… key immunotherapeutic approaches to deal with COVID-19, which is discussed in this review…
Also, details of leading COVID-19 vaccine candidates as the most potent immunotherapy …

… guidance with possible treatment options for when patients fail to respond and there is a
clear clinical rationale for an alternative therapy, even if not yet formally tested in large RCTs. …

… administration, passive immunotherapy by convalescent … immunotherapeutic approaches
that will be mentioned in this review. The focus would be on passive immunotherapeutic …

… option for the management of COVID-19 patients. Another multicenter retrospective cohort
study indicated that IVIG therapy could benefit critical COVID19 patients, … of patients based on …

… management for patients with severe COVID-19 disease. A … immunotherapeutic options
to ameliorate cytokine storm and inflammatory responses in patients affected with COVID-19…

… in patient’s with Corona Virus Disease 2019 (CoViD-19) was … on 522 patients with confirmed
CoViD-19 symptomatology, … ) as patients (n=14) deteriorated from prodromal to symptomatic …

… to its fast onset of activity and high efficacy but that is not necessarily considered a long-term
option) during the COVID-19 pandemic, and the first reports of SARS-CoV-2 infection in …

… Passive immunotherapy has been used as a reliable treatment option for many infectious …
, and immunogenicity of passive immunotherapy for the treatment of COVID-19. As of now on 9 …

… study, within 19 days after symptom onset, 100% of patients tested … and proliferation in patients
with COVID-19, especially in … patients with relatively high B cell levels have poor survival. …